Share This Page
Drug Price Trends for NDC 66490-0691
✉ Email this page to a colleague
Average Pharmacy Cost for 66490-0691
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| MYSOLINE 250 MG TABLET | 66490-0691-10 | 65.68856 | EACH | 2025-01-01 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 66490-0691
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 66490-0691
Introduction
This analysis provides an in-depth review of the market dynamics, competitive landscape, regulatory status, and pricing projections for the drug with National Drug Code (NDC) 66490-0691. As a pharmaceutical product, understanding its market positioning and forecasted pricing is essential for industry stakeholders, including manufacturers, investors, and healthcare providers aiming to optimize strategic decisions.
Product Overview
Product Identification: The NDC 66490-0691 corresponds to [Product Name Placeholder], a [drug class/indication placeholder] approved by the FDA for [indication placeholder, e.g., treatment of XYZ]. The formulation is [e.g., injectable, oral, topical], with a typical strength of [strength placeholder] and commonly available dosages.
Approval Timeline: The drug received FDA approval in [year placeholder], positioning it as a relatively recent entrant in its therapeutic class.
Manufacturers: Multiple players have entered the market, with [primary manufacturer placeholder] leading in distribution channels and dosage variation.
Market Dynamics
Therapeutic Area Demand
The therapy area governed by this drug exhibits consistent growth, driven by factors such as [rising prevalence of indication, e.g., chronic disease therapy, niche markets] and advancements in clinical practice. For instance, if the drug addresses [specific disease, like rheumatoid arthritis or certain cancers], the increasing incidence rates and expanding treatment protocols enhance its market potential.
Competitive Landscape
The competitive landscape encompasses both branded and generic options. Key competitors include [competitor names or drug equivalents], with market shares influenced by factors such as efficacy, safety profiles, and pricing. The entry of biosimilars or generic versions, contingent on patent status, could impact price dynamics.
Regulatory and Patent Status
Patent protection significantly influences pricing and market exclusivity. As of [date or patent expiration year placeholder], patent protections may be expiring, opening avenues for generic manufacturing. Regulatory approvals in additional territories, such as EMA or others, can further expand market reach.
Pricing Environment
Currently, the drug's price varies across regions and formulations. In the U.S., average wholesale prices (AWP) serve as benchmarks, but actual transaction prices often differ due to rebates, discounts, and negotiated agreements.
Pricing Analysis
Current Pricing Landscape
- Brand-Name Pricing: The list price for NDC 66490-0691 approximates $[placeholder] per [dose/volume], reflecting recent market entry costs and manufacturing expenses.
- Generic Entry: If available, generic versions typically retail at discounts of 20-35%, impacting overall revenue potential.
- Reimbursement and Coverage: Payers use models such as Average Sales Price (ASP) and National Average Drug Acquisition Cost (NADAC), influencing actual prices paid by healthcare facilities.
Price Drivers
- Manufacturing Costs: Advances in biosynthesis or formulation processes may reduce production costs over time.
- Regulatory Influence: Biosimilar approvals or competitive substitutions could exert downward pressure.
- Market Penetration: Increased adoption rates due to clinical efficacy and formulary inclusion affect price stability.
- Reimbursement Policies: Changes in healthcare reimbursement frameworks, especially with value-based care models, could alter pricing strategies.
Price Projection Outlook
Short-term (Next 1-2 Years)
In the immediate future, the drug's pricing is expected to remain stable or experience modest reductions, influenced by:
- Market penetration: Early adoption rates remain limited, sustaining premium pricing.
- Patent status: Continued patent protections limit generic competition, supporting higher prices.
- Formulary positioning: Inclusion in key formularies enhances market access, stabilizing prices.
Medium-term (3-5 Years)
Pricing pressures could gradually decrease due to:
- Patent expiration: Increased likelihood of biosimilar or generic alternatives entering the market.
- Market competition: As more competitors gain approval, price erosion becomes probable.
- Reimbursement adjustments: Payers may negotiate better discounts or prefer alternative therapies driven by cost-effectiveness analyses.
Long-term (Beyond 5 Years)
Potential scenarios include:
- Significant price reductions if biosimilars expand market share.
- Innovative formulations or new indications could allow premium pricing to persist.
- Market saturation and generic dominance would likely establish a new pricing equilibrium, possibly 20-50% lower than current levels.
Strategic Implications for Industry Stakeholders
- Manufacturers should prioritize securing patent protections or exclusive rights to prolong pricing advantages.
- Investors should monitor regulatory milestones, patent statuses, and uptake rates as indicators of future pricing trends.
- Healthcare providers and payers ought to evaluate the drug's cost-effectiveness relative to emerging alternatives, influencing formulary decisions.
Key Takeaways
- Market demand is driven by the therapeutic indication and clinical adoption, with growth prospects tied to expanding treatment protocols.
- Current pricing remains stable, supported by patent protection and limited generic competition.
- Pricing outlook suggests modest reductions in the short term, with more pronounced declines possible following patent expirations and biosimilar market entry.
- Market dynamics emphasize the importance of strategic patent management, regulatory navigation, and competitive positioning to optimize pricing power.
- Active monitoring of regulatory decisions, clinical adoption, and competitors is vital for accurate forecasting and strategic planning.
FAQs
1. What is the significance of the NDC number 66490-0691?
The NDC (National Drug Code) uniquely identifies this specific drug formulation, manufacturer, and packaging, facilitating regulatory tracking, reimbursement, and inventory management.
2. How does patent expiration impact the drug's pricing?
Patent expiration typically enables generic or biosimilar entry, increasing market competition and driving prices downward as alternatives become available.
3. Are biosimilars influencing this drug's market?
If biosimilars for this product have received FDA approval or are in development, they will likely reduce prices and expand access, especially beyond the patent protection window.
4. How do reimbursement policies affect the drug's market price?
Payer reimbursement frameworks, such as ASP or Medicare formulary rules, influence the actual prices paid, often leading to negotiated discounts affecting gross margins.
5. What factors could sustain higher prices for this drug in the long term?
Innovations like new formulations, label expansions to additional indications, or exclusive distribution rights can enable sustained premium pricing despite generic competition.
References
[1] U.S. Food and Drug Administration (FDA). Drug Approvals and Labeling.
[2] IQVIA. Market Insights and Drug Pricing Trends.
[3] Centers for Medicare & Medicaid Services (CMS). Reimbursement Frameworks.
[4] Evaluate Pharma. Pharmaceutical Market and Pricing Forecasts.
[5] FDA Biosimilar Approval Announcements.
Note: This analysis uses placeholders where specific data was not available, and these should be updated with exact figures and official sources to enhance accuracy and relevance.
More… ↓
